Skip to main content
Premium Trial:

Request an Annual Quote

Dante Labs Software Nabs CE Mark for Interpretation of Whole-Genome Sequencing Data

NEW YORK – Dante Labs announced Tuesday its Immensa software received CE-IVD marking for the interpretation of whole-genome sequencing data in a clinical setting at scale.

The software generates personalized reports for pharmacogenomics, rare diseases, predisposition to common diseases, and nutrigenomics, and integrates guidelines from the American College of Medical Genetics, the company said.

It was built using more than 150,000 genomic reports generated by Dante Labs and integrated user feedback. The software takes 30 seconds to generate a report and can scale with demand, the firm said.

Dante Labs CEO Andrea Riposati said in a statement the software will be available commercially to clinics and hospitals in countries accepting the CE mark "in a few weeks."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.